Risk allele for side effects induced by Clozapine identified
Wednesday, April 6, 2016 - 09:10
in Health & Medicine
Clozapine (CLZ) is a “gold standard” drug for managing treatment-resistant schizophrenia, who do not respond adequately to first-line antipsychotics. However, despite its efficacy, the use of CLZ is significantly restricted by severe side effects, which are rare but potentially life-threatening.